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Research
Perinatal exposure to environmental toxi  cants 
such as lead, methylmercury, pesticides, and 
polychlorinated biphenyls increases the risk of 
developmental disabilities, mental retardation, 
neuorosensory alterations, and psychiatric 
morbidity (Grandjean and Landrigan 2006; 
Mendola et al. 2002). The spectrum of neuro-
toxic effects depends on the perinatal period of 
exposure, concentration and duration of expo-
sure, and genetic susceptibility (Grandjean and 
Landrigan 2006; Rice and Barone 2000). This 
is exemplified best by lead exposure, which is 
especially neurotoxic to the developing cen-
tral nervous system: Children with blood lead 
concentrations ([BPb]) < 10 µg/dL—the cur-
rent low level of concern [Centers for Disease 
Control and Prevention (CDC) 1991]—have 
cognitive deficits and neurosensory alterations 
(Grandjean and Landrigan 2006; Rothenberg 
et al. 2002). 
The phenotype of retinal alterations is 
markedly dependent on the develop  mental 
exposure period. After post  natal lead exposure, 
rod photoreceptor-selective apoptosis, persistent 
rod-mediated (scotopic) electro  retinographic 
(ERG) sub  normality, and scotopic behavioral 
deficits occur in humans, monkeys, and rodents 
(Fox and Boyes 2008; Fox et al. 1997; He et al. 
2003). In contrast, children, monkeys, and rats 
with low-dose (LD) to moderate-dose (MD) 
gestational lead exposure (GLE) exhibit novel 
scotopic ERG super  normality (Fox et al. 2008; 
Lilienthal et al. 1994; Nagpal and Brodie 2009; 
Rothenberg et al. 2002).
The adult mammalian retina consists of 
six neuronal cell types and a Müller glial cell 
(MGC) that originate from a pool of multi-
potent retinal progenitor cells (RPCs) (Livesey 
and Cepko 2001; Young 1985a). Retinogenesis 
proceeds in two distinct yet over  lapping 
histo  genetic periods, charac  terized by the 
development of early-born cells (ganglion, hori-
zontal, cone, and amacrine cells) mostly during 
embryo  genesis and late-born cells [rods, bipo-
lar cells (BCs), and MGCs] during early post-
natal develop  ment (Livesey and Cepko 2001; 
Martins and Pearson 2008; Young 1985b). 
Approximately 70% of adult [postnatal day 60 
(PND60)] mouse retinal cells are rods, and 
20% are BCs (Strettoi and Volpini 2002; 
Young 1985a). Extrinsic factors such as neuro-
transmitters and modulators alter the cell fate 
of RPCs; however, these changes are limited by 
the intrinsic properties of RPCs (Livesey and 
Cepko 2001; Martins and Pearson 2008). LD 
and MD GLE produced a novel retinal pheno-
type in PND60–PND90 rats charac  terized 
by an increased number of cells in the outer 
nuclear layer (ONL) and inner nuclear layer 
(INL) with no change in glial fibrillary acid 
protein content, suggesting that GLE selectively 
increased the number of late-born neurons but 
not MGCs (Fox et al. 2008).
The goals of our study were to use our 
mouse model of GLE (Leasure et al. 2008) 
to test the hypothesis that GLE selectively 
increases neurons in the scotopic signaling path-
way and to determine the cellular mechanisms 
underlying the phenotype. To accomplish this, 
we determined the number and distribution of 
early- and late-born retinal cell types in PND60 
control and GLE offspring; kinetics of RPC 
mitosis, proliferation, and cell-specific apoptosis 
during development; and spatio  temporal pat-
tern and number of developing late-born cells 
with 5-bromo-2-deoxyuridine (BrdU) birth 
dating. The results reveal that GLE increases 
and prolongs RPC proliferation without 
decreasing apoptosis. This produced an adult 
retina with normal lamination and a selectively 
increased number of rods and BCs.
Materials and Methods
Animal model. All experimental and animal 
care procedures complied with the National 
Institutes of Health (NIH) Public Health 
Service Policy on the Humane Care and Use 
of Laboratory Animals (NIH 2002) and were 
approved by the Institutional Animal Care and 
Use Committee of the University of Houston. 
All animals were treated humanely and with 
regard for alleviation of suffering. The GLE 
model, as described by Leasure et al. (2008), 
uses C57BL/6 mice. Briefly, female mice fed 
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Ba c k g r o u n d: Gestational lead exposure (GLE) produces novel and persistent rod-mediated 
electro  retino  graphic (ERG) supernormality in children and adult animals. 
oBjectives: We used our murine GLE model to test the hypothesis that GLE increases the number 
of neurons in the rod signaling pathway and to determine the cellular mechanisms under  lying the 
phenotype. 
re s u l t s: Blood lead concentrations ([BPb]) in controls and after low-, moderate-, and high-
dose GLE were ≤ 1 , ≤ 10, approximately 25, and approximately 40 µg/dL, respectively, at the 
end of exposure [postnatal day 10 (PND10)]; by PND30 all [BPb] measures were ≤ 1 µg/dL. 
Epifluorescent, light, and confocal microscopy studies and Western blots demonstrated that late-
born rod photo  receptors and rod and cone bipolar cells (BCs), but not Müller glial cells, increased in 
a nonmonotonic manner by 16–30% in PND60 GLE offspring. Retinal lamination and the rod:cone 
BC ratio were not altered. In vivo BrdU (5-bromo-2-deoxyuridine) pulse-labeling and Ki67 labeling 
of isolated cells from developing mice showed that GLE increased and prolonged retinal progenitor 
cell proliferation. TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) and con-
focal studies revealed that GLE did not alter developmental apoptosis or produce retinal injury. BrdU 
birth-dating and confocal studies confirmed the selective rod and BC increases and showed that the 
patterns of neuro  genesis and gliogenesis were unaltered by GLE. 
co n c l u s i o n s: Our findings suggest two spatiotemporal components mediated by dysregulation 
of different extrinsic/intrinsic factors: increased and prolonged cell proliferation and increased neu-
ronal (but not glial) cell fate. These findings have relevance for neurotoxicology, pediatrics, public 
health, risk assessment, and retinal cell biology because they occurred at clinically relevant [BPb] 
and correspond with the ERG phenotype.
key w o r d s : bipolar cells, development, gestational exposure, glia, lead, mice, neurogenesis, pro-
liferation, retina, rod photoreceptors. Environ Health Perspect 119:71–77 (2011).  doi:10.1289/
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Purina lab chow 5001 (Purina Mills, St. Louis, 
MO) were given water (control) or water con-
taining a low (27 ppm), moderate (55 ppm), or 
high (109 ppm) concentration of lead 2 weeks 
before mating, during pregnancy, and through 
PND10 to produce a human-equivalent   
GLE. Dams were mated with a control male 
overnight, and the presence of a vaginal plug 
was recorded as gestation day (GD) 0.5. On 
PND10, we replaced the lead solutions with 
water. Litter sizes were maintained at six pups 
each until weaning (PND21). Mice were 
sacrificed by decapitation between 1000 and 
1200 hours on PND1, PND3, PND5, PND7, 
PND10, and PND60. We observed no differ-
ences between sexes for any end point.
As described by Leasure et al. (2008), 
control, LD, MD, and high-dose (HD) GLE 
groups had peak [BPb] on PND0 and/or   
PND10 of 0.72 ± 0.07, 10.10 ± 0.65, 
27.23 ± 1.39, and 42.06 ± 0.70 µg/dL, respec-
tively; on GD14 the dam’s [BPb] was similar 
to that of PND0 pups; and on PND30 the 
[BPb] in GLE mice were not different from 
those in controls (n = 10–15 mice/treatment 
group/age). There were no statistical differ-
ences between control and GLE groups on any 
dam measure, litter meas  ure, or body weight.
Retinal epifluorescent, light, and immuno-
cyto  chemistry/confocal microscopy studies. All 
tissue processing, image acquisition, and analy-
sis procedures were as described previously (Fox 
et al. 1997, 2008; He et al. 2003; Johnson 
et al. 2007). Briefly, eyes were removed and 
immersed in ice-cold phosphate-buffered saline 
(PBS), corneas were slit, and eyes were immer-
sion fixed in buffered 4% paraformaldehyde for 
30 min (confocal microscopy) or Karnovsky’s 
fixative (light microscopy). For confocal 
microscopy, central sections (10 µm thick) 
from cryo  protected frozen retinas were cut at 
200–400 µm from the optic nerve. Nuclear 
dyes and primary anti  bodies directed against 
retinal-cell-type–specific and cell-cycle markers 
were used (Table 1). ONL and INL thickness 
was measured on 4´,6-diamidino-2-phenyl-
indole (DAPI)-stained slides using a calibrated 
filar micrometer eyepiece. For light micros-
copy, superior central retinal sections were 
embedded in Araldite (Electron Microscopy 
Sciences, Hatfield, PA), sectioned (1 µm), and 
stained with toluidine blue for rod and cone 
photoreceptor counting. Twenty fields, each 
100 µm in length, were examined.
For all studies, slides (three nonadjacent 
coded sections) from each treatment group were 
analyzed using identical exposure and scanning 
parameters. The images were processed identi-
cally using Adobe Photoshop software (Adobe 
Systems Incorporated, San Jose, CA). All cell 
counts were conducted using Image-Pro Plus 
(Media Cybernetics Inc., Bethesda, MD) by 
an observer who was masked to the exposure 
type and who used unbiased stereology and 
morpho  logic criteria, as described previously 
(He et al. 2003; Lucocq 2007). 
For pulse-labeling cells in S phase (Rachel 
et al. 2002), BrdU (50 µg/g) was injected 
intraperitoneally (IP) into pregnant dams on 
GD16.5 and GD18.5, and pups were injected 
on PND1, PND3, PND5, and PND7. Mice 
were sacrificed 2.5 hr after injection. For birth 
dating late-born retinal cells, two doses of 
BrdU (100 µg/g) were injected into PND1, 
PND3, PND5, and PND7 pups separated 
by 2 hr, and mice were sacrificed on PND60. 
Slides were triple labeled with an anti-BrdU 
antibody, the nuclear stain DRAQ5, and 
antibodies for rods, BCs, or MGCs and 
then processed for confocal microscopy and 
counting as previously described (He et al. 
2003; Johnson et al. 2007). We used stain-
ing, morphologi  cal, and pixel density criteria 
(≥ 20 pixels at 300 dpi) to identify and count 
BrdU-immunoreactive (BrdU-IR) cells, as pre-
viously described (Rachel et al. 2002).
Western blotting. Immunoblotting was 
performed as described previously (Fox et al. 
2008; He et al. 2003). Briefly, both retinas 
were removed, cleaned in PBS, and frozen at 
–80°C until use. Thawed retinas were homog-
enized in lysis buffer and centrifuged, and 
20–30 µg protein was loaded onto SDS-PAGE 
gels. Blots were probed with selected primary 
anti  bodies using GADPH as a loading con-
trol (Table 1), incubated with horseradish 
peroxidase–conjugated secondary antibody, 
and visualized with ECL Plus (GE Healthcare, 
Piscataway, NJ). Densitometry measurements 
were obtained using ImageJ software (NIH 
2009) from non  saturated blots. 
Immunolabeling dissociated progenitor 
cells. We followed the procedure for single-cell 
dissociation of PND2, PND4, and PND6 reti-
nas as described previously by He et al. (2000), 
except that we replaced HEPES with Hank’s 
balanced salt solution. Dissociated cells (106 
cells/mL) were pipetted onto slides, fixed with 
4% paraformaldehyde, rinsed, and air dried. 
Coded slides were double labeled for Ki67 and 
DRAQ5 and processed for confocal micros-
copy and counting as previously described (He 
et al. 2000).
Terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL). Apoptotic 
cells were labeled using the ApoAlert DNA 
Fragmentation Assay TUNEL Kit (Clontech, 
Mountainview, CA) according to manufac-
ture’s procedure. Briefly, reti  nal sections were 
dried and fixed with 4% paraformaldehyde, 
incubated with proteinase K, and washed, fixed, 
and washed again. Slides were incubated with 
equilibrium buffer, sequentially incubated with 
terminal deoxynucleo  tidyl transferase (TdT) 
and sodium chloride/sodium citrate, washed, 
and cover  slipped with Vectashield Mounting 
Medium with DAPI (Vector Laboratories). 
Positive-control (DNase1) and negative-control 
(no TdT) slides were processed simultaneously 
for each experiment. Fluorescent apoptotic cells 
were identified in different retinal layers using 
stringent morphologic criteria and counted as 
previously described (He et al. 2000, 2003).
Statistical analysis. Only one animal 
per litter was used for each measure. Data 
Table 1. Cell-specific primary antibodies and dyes.
Name 
Structure labeled  
or targeted Host Product number and source Dilution
BrdU S-phase marker Rat Ab6326; Abcam Inc., Cambridge, MA 1:40
ChAT Amacrine cells Rabbit Ab143; Chemicon, Temecula, CA 1:100
Chx10 BCs Sheep X1180P; Exalpha Biologicals Inc., Shirley, MA 1:50
Cyclin D3 MGC nucleus Mouse MCA1866; Serotec, Raleigh, NC 1:40 
DAPI Nucleus H-1200; Vector Laboratories, Burlingame, CA 1.5 µg/mL
DRAQ5 Nucleus BOS-889-001; Alexis Biochemicals; Enzo Life Sciences International Inc., 
Plymouth Meeting, PA
20 µM
Glutamine synthetase MGCs Rabbit G2781; Sigma Aldrich, St. Louis, MO 1:5,000
Glyceraldehyde 3-phosphate 
dehydrogenase
Protein loading control Mouse MAB 374; Millipore, Billerica, MA 1:300
Ki67 Progenitor cell marker Mouse 500609; BD, Franklin Lakes, NJ 1:100
Opsins (middle- and short- 
wavelength sensitive)
Cones Rabbit Gifts from C. Craft, University of Southern California, Los Angeles, CA 1:1,000
PH3 M-phase marker Rabbit 56-0701; Upstate Biotech, Lake Placid, NY  1:40
PKCα Rod BCs Rabbit P4334; Sigma Aldrich  1:1,000
Rhodopsin Rod photoreceptors Mouse MAB5356; Chemicon  1:5,000Lead causes retinal proliferation and neurogenesis
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represent four to seven retinas, each from a 
different mouse, at each age per treatment 
group. Group data were analyzed by   analysis 
of variance followed by post hoc mul-
tiple comparisons using Tukey’s honestly 
significant difference test (KaleidaGraph; 
Synergy Software, Reading, PA). Data are 
presented as mean ± SE, and the difference 
from controls was regarded as significant if 
p < 0.05.
Results
GLE increased retinal ONL and INL thick-
ness. DAPI nuclear staining revealed that GLE 
increased the cell density and thickness of the 
ONL and INL in PND60 mice (Figure 1A). 
Figure 1. GLE selectively increases the number of rod photoreceptors and BCs in the adult (PND60) mouse retina as shown in light and confocal microscopy 
studies. (A) Representative DAPI nuclear labeling shows that ONL (rod and cone nuclei), INL (horizontal, bipolar, amacrine, and MGC nuclei), outer plexiform 
layer (OPL), inner plexiform layer (IPL), and total retinal thickness increased in retinas from animals in the LD, MD, and HD GLE groups. Retinal GCL cellularity and 
retinal lamination were not different in control and GLE retinas. (B–E) Representative double-labeled confocal microscopy studies reveal rod and BC selectivity of 
the retinal phenotype. (B) The number of rhodopsin-IR rod nuclei and PKCα-IR rod BC somas—in distal (upper) INL—increased in GLE retinas. (C) The numbers of 
cone outer segments (OS) immuno  reactive for middle- and short-wavelength–sensitive opsin (M-/S-opsin) and horizontal cells immuno  reactive for calbindin were 
not different in control and GLE retinas. (D) The numbers of Chx10-IR BC nuclei and Chx10/PKCα colabeled rod BCs increased in adult GLE retinas. (E) The number 
of cyclin D3–IR MGCs colabeled with glutamine synthetase (GS), were similar in adult control and GLE retinas. Bars = 20 µm for A and for B–E. 
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GLE also increased the thickness of the 
outer and inner plexiform (synaptic) layers 
and total retinal thickness (Figure 1A). The 
central ONL and INL of controls contained 
10–11 and 4–5 nuclei/layer, respectively, 
and were 54.0 ± 2.4 and 37.2 ± 2.1 µm thick 
(mean ± SE), respectively. In LD, MD, and 
HD GLE mice, ONL thickness significantly 
increased by 18.3 ± 1.5%, 25.5 ± 2.2%, 
and 8.4 ± 1.2%, respectively; INL thick-
ness significantly increased by 21.4 ± 1.6%, 
29.8 ± 2.5%, and 18.0 ± 1.9%, respectively; 
and total retinal thickness significantly 
increased by 25.7 ± 2.1%, 30.4 ± 2.8%, and 
15.7 ± 1.5%, respectively. The number of 
DAPI-stained nuclei in the retinal ganglion 
cell layer (GCL) of controls (15.4 ± 1.5 per 
100 µm length) was not significantly different 
in GLE mice (Figures 1A and 2A).
GLE selectively increased the number of 
rods. We conducted additional studies to 
characterize and quantify the cell-specific 
increase in ONL thickness. Rhodopsin-labeled 
retinas showed that GLE increased ONL cel-
lularity and thickness (Figure 1B). In GLE 
mice, the density of cone outer segments 
immuno  reactive for middle- and short-
wavelength–sensitive opsin was not signif-
icantly different from controls (Figure 1C; 
15.4 ± 0.8 per 100 µm length). Stereo  logic 
analysis showed that GLE selectively and 
significantly increased the number of rods 
(Figure 2A). In controls, the numbers of cen-
tral rod and cone nuclei were 126.5 ± 3.4 
and 3.9 ± 0.2 per 100 µm length, respec-
tively, consistent with previously published 
results (He et al. 2003). In LD, MD, and HD 
GLE mice, the numbers of rods significantly 
increased by 16.9 ± 4.7%, 27.3 ± 5.3%, and 
9.5 ± 1.6%, respectively; however, cone den-
sity was unchanged (Figure 2A). Immuno-
blots showed that the rhodopsin content 
significantly increased in LD, MD, and HD 
GLE retinas by 21.1 ± 1.5%, 34.3 ± 2.7%, 
and 14.0 ± 2.6%, respectively (Figure 2B). 
Collectively, these findings demon  strate 
that GLE increased the number of rod, but 
not cone, photoreceptors in PND60 mice. 
Furthermore, these non  monotonic effects 
for the stereology and Westerns blots were 
characterized by an inverted U-shaped dose–
response curve.
GLE selectively increased the number of 
BCs. Additional studies were conducted to 
determine the INL cell types that increased. 
We double-labeled retinal sections with an 
anti-Chx10 antibody, a selective marker for 
differentiated rod and cone BCs, and an 
anti-protein kinase Cα (anti-PKCα) anti-
body that selectively labels rod BCs (Green 
et al. 2003). In GLE retinas, the number of 
Chx10-IR BCs increased (Figure 1D). In 
controls, we observed 56.8 ± 4.5 Chx10-IR 
cells per 100 µm length of central retina. In 
LD, MD, and HD GLE mice, this signifi-
cantly increased by 16.3 ± 4.7%, 26.7 ± 4.7%, 
and 19.8 ± 5.2%, respectively (Figure 2A). 
Immuno  blots showed that Chx10 content 
significantly increased in LD, MD, and HD 
GLE retinas by 18.3 ± 1.6%, 31.4 ± 2.8%, 
and 20.4 ± 3.1%, respectively (Figure 2B). 
In GLE retinas, the number of PKCα-IR rod 
BCs exhibited simi  lar increases (Figure 1D). 
The number of PKCα-IR rod BCs in con-
trol central retina was 18.4 ± 1.5 per 100 µm 
length, and they significantly increased in LD, 
MD, and HD GLE mice by 17.9 ± 3.1%, 
24.9 ± 3.7%, and 18.9 ± 2.7%, respectively 
(Figure 2A). This yielded rod BC:total BC 
ratios of 0.31–0.34 for control and GLE reti-
nas, which are normal ratios for mammalian 
retina (Strettoi and Volpini 2002). Immuno-
blots showed that PKCα content significantly 
increased in LD, MD, and HD GLE retinas by 
19.4 ± 1.4%, 24.8 ± 2.2%, and 21.0 ± 2.5%, 
respectively (Figure 2B). In control and GLE 
mice, the density of calbindin-IR horizontal 
cells (Figure 1C) and cyclin D3-IR MGCs 
(Figure 1E) in central retina (1.4 ± 0.1 and 
10.5 ± 0.5 per 100 µm length, respectively) 
was not significantly different (Figure 2A). 
Immunoblots for glutamine synthetase 
revealed no significant differences (Figure 2B), 
consistent with the confocal and morpho-
metric MGC results (Figures 1E and 2A). We 
observed no glial fibrillary acid protein label-
ing or content change in any retinas (Fox DA, 
Giddabasappa A, Chaney S, unpublished 
data), similar to our results in GLE rats (Fox 
et al. 2008), indicating that GLE produced no 
injury response. The density of choline acetyl-
transferase-IR (ChAT-IR), γ-aminobutyric 
acid–IR, and Disabled-1–IR (Dab1 glyciner-
gic AII) amacrine cells in control central INL 
was 1.9 ± 0.2, 7.3 ± 0.5, and 4.8 ± 0.3 per 
100 µm length, respectively. This yielded a 
Disabled-1:ChAT INL amacrine cell ratio of 
2.5:1, which is consistent with our calculated 
values from published data (Jeon et al. 1998; 
Rice and Curran 2000). We found no signifi-
cant differences in these amacrine cell densities 
in GLE retinas (Figure 2A). Immunoblots 
for ChAT confirmed the stereo  logy results 
(Figure 2B). These composite results demon-
strate that GLE selectively and proportionately 
increased the number of rod and cone BCs 
without altering the cell fate of other cells. 
Furthermore, the non  monotonic effects were 
characterized by an inverted U-shaped dose–
response curve.
BrdU birth-dating studies. To determine 
the spatio  temporal kinetics of late-born reti-
nal cells, we conducted BrdU double-labeling 
experi  ments with anti-rhodopsin (Figure 3A), 
anti-Chx10 (Figure 3B), or anti-cyclin D3 
antibodies (Figure 3C). GLE selectively and 
Figure 2. GLE selectively increases the number of rod photoreceptors and BCs in retinas from adult mice. (A) Unbiased stereological analyses of major retinal cell 
types in adult retinas show that LD, MD, and HD GLE produced selective and significant non  monotonic increases in the number of rods and BCs, relative to con-
trols. Values are mean ± SE from three non  adjacent sections per retina from four to seven retinas per treatment group, with each retina from a different mouse. 
(B) Representative Western blots reveal that GLE increased the retinal content of rhodopsin, Chx10, and PKCα but did not change the amount of glutamine syn-
thetase (GS) or amacrine cell ChAT content. GAPDH was used as the protein loading control. 
*p < 0.05, compared with control. Groups sharing # or † were significantly different within the cell type at p < 0.05.
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significantly increased rod and BC neuro-
genesis by 35–40% from PND1 to PND5 
while maintaining normal cellular migration 
and lamination, which confirms and extends 
our findings. For control and GLE, the rod, 
BC, and MGC peak birth dates were PND1, 
PND3, and PND3, respectively, consistent 
with previously published results (Young 
1985b). Thus, MD GLE did not disrupt the 
initiation or pattern of neuro  genesis or glio-
genesis, despite increasing rod and BC neuro-
genesis by approximately 30% (Figure 2A). 
Two possible, although not mutually exclu-
sive, mechanisms might underlie these selec-
tive changes: increased proliferation and/or 
decreased apoptosis.
GLE increased and prolonged the prolifera-
tion of RPCs. We conducted BrdU pulse- 
labeling studies to determine if the increased 
rod and BC neuro  genesis resulted from 
increased RPC prolifera  tion. Figure 4A shows 
that BrdU labeled the central neuro  blastic layer 
(NBL) from GD16.5 to PND3, consistent 
with the termination of DNA synthesis by 
PND5 (Young 1985a). The labeling pattern 
in controls (Figure 4B) was similar to that for 
[3H]-thymidine labeling in developing rat reti-
nal explants (Alexiades and Cepko 1996). In 
MD GLE retinas, BrdU labeling persisted until 
PND5 (Figure 4A,B); we observed no BrdU-IR 
cells on PND7 (Figure 4B). From GD16.5 to 
PND3, GLE significantly increased the num-
ber of BrdU-IR cells by 30% (Figure 4B).
To assess whether GLE affected the 
spatio  temporal pattern and/or number of 
RPCs undergoing mitosis, we double-labeled 
retinas with anti-phosphohistone H3 (anti-
PH3) and anti-BrdU antibodies. PH3 labeled 
cells only in the apical NBL/subventricular 
zone, the site of retinal mitosis (Alexiades and 
Cepko 1996; Barton and Levine 2008; Young 
1985a), where approximately 10% colocal-
ized with BrdU cells on GD16.5 and GD18.5 
(Figure 4A). Although the spatio  temporal 
Figure 3. BrdU birth-dating and confocal studies demonstrate that MD GLE selectively and significantly 
increased the number of rods and BCs in retinas from adult mice. GLE did not alter the kinetics of neurogenesis 
and gliogenesis. BrdU-IR and rhodopsin-IR rods (A) and BrdU-IR and Chx10-IR BCs (B) increased in GLE retina, 
compared with controls. (C) No differences in the number of BrdU-IR and cyclin D3–IR MGCs were observed 
in control and GLE retinas. Values are mean ± SE of IR cells per 400 µm of central retina and and represent 
from four to seven retinas at each age per treatment group, with each retina from a different mouse. 
*p < 0.05, and **p < 0.01 compared with controls. 
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Figure 4. MD GLE increases and prolongs RPC proliferation in vivo and ex vivo. (A) The M-phase marker PH3 and S-phase marker BrdU are present until PND3 in 
controls and PND5 in GLE central retina. They colocalize in the distal NBL. At all ages, except PND7, there are more BrdU-IR and PH3-IR cells in the GLE retinas. 
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and DRAQ5; results reveal that GLE significantly increased RPCs in an age-dependent manner, similar to that shown in B. In B–D, values are mean ± SE from four 
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pattern of PH3 labeling was simi  lar in control 
and GLE retinas, GLE significantly increased 
the number of PH3-IR cells by 25% from 
GD16.5 to PND3 (Figure 4C).
To explore possible GLE-induced altera-
tions in cell cycle progression, we calculated 
PH3:BrdU ratios for controls and GLE dur-
ing the period of significantly increased RPC 
proliferation. The ratios (0.10–0.12), similar 
to those obtained with PND1 mouse reti-
nas by [3H]-thymidine pulse-labeling (Young 
1985a), were not significantly different at any 
age. This indicates that GLE did not alter the 
relative time spent in S and M phases.
To further confirm the pulse-labeling 
BrdU proliferation results, we double-labeled 
dissociated single cells from developing 
retinas with an anti-Ki67 antibody and the 
nuclear stain DRAQ5. Figure 4D reveals that 
43.6 ± 0.9%, 23.0 ± 1.4%, and 10.5 ± 1.5% 
of the control retinal cells were proliferating 
at PND2, PND4, and PND6, respectively, 
consistent with rodent studies using differ-
ent techniques to estimate the percentage of 
proliferating cells (Alexiades and Cepko 1996; 
Barton and Levine 2008; Young 1985a). In 
GLE retinas, the number of proliferating cells 
significantly increased on PND2, PND4, and 
PND6 in GLE by 60.5 ± 2.9%, 32.1 ± 2.7%, 
and 20.9 ± 1.0%, respectively (Figure 4D). 
These results, which are consistent with the 
BrdU data (Figure 4B), demon  strate that 
GLE increased the proliferation of late-born 
retinal cells.
GLE did not alter retinal apoptosis dur-
ing development. A GLE-induced decrease in 
apoptosis could increase the number of pro-
liferating RPCs and differentiated neurons. 
In the NBL of control and MD GLE reti-
nas, TUNEL-positive cells exponentially and 
similarly increased from GD16.5 to PND5 
(Figure 5A,B). In the GCL of control and 
MD GLE retinas, TUNEL-positive cells 
increased linearly from GD16.5 to PND3 
and then decreased, resulting in an inverted 
U-shaped curve (Figure 5C). On PND1 and 
PND7, TUNEL-positive cells in the GCL 
were slightly, but significantly, increased and 
decreased in MD GLE mice, respectively. 
However, we found no significant differences 
in GCL cellularity at PND60 (Figures 1A and 
2A). In the ONL of control and GLE retinas, 
TUNEL-positive cells were low on PND7 
and PND10 and not significantly different. 
Although numbers of TUNEL-positive cells 
were 20- to 30-times higher in control and 
GLE INL than in the ONL on PND7 and 
PND10, there were no significant differences 
between treatment groups (Figure 5D). The 
spatio  temporal patterns and amount of apop-
tosis in controls were simil  ar to previously 
published results (He et al. 2003; Portera-
Cailliau et al. 1994; Young 1984). Thus, 
the GLE-induced increase in proliferating 
RPCs and late-born neurons was not due to 
decreased apoptosis.
Discussion
We obtained three novel results with our 
murine model of GLE. First, GLE produced 
selective non  monotonic increases, charac-
terized by an inverted U-shaped dose–response 
curve, in the numbers of rods and BCs in the 
adult retina. The increase in rods and BCs 
did not alter retinal lamination or the pro-
portion of rod and cone BCs. Second, GLE 
increased and prolonged RPC proliferation 
without changing the relative S- or M-phase 
length, initiation of neuro    genesis, or pattern 
of neuro    genesis and glio    genesis. Third, GLE 
did not significantly alter apoptosis or produce 
reactive gliosis during retinal development and 
maturation.
The molecular mechanisms responsible for 
the novel GLE-induced retinal phenotype are 
unknown. However, the increased and pro-
longed RPC proliferation accompanied by the 
selective increase in late-born neurons suggests 
that two different spatio    temporal components 
are involved. We deduce that the first involves 
a modest increase in the number of cell cycles, 
and the second involves factors that regu  late 
rod and BC fate. Multiple extrinsic and intrin-
sic factors regulate RPC proliferation and cell 
fate decisions during develop    ment (Livesey 
and Cepko 2001; Martins and Pearson 2008). 
Figure 5. MD GLE does not change the amount or pattern of retinal apoptosis during development. (A) TUNEL-positive cells in control and GLE retinas from GD16.5 
to PND10. Bar = 100 µm. (B) The number of TUNEL-positive cells increased rapidly in the NBL during development, however, there were no age-dependent differ-
ences between control and GLE mice. (C) Although the kinetics of TUNEL-positive cells differed slightly in the retinal GCL of control and GLE retinas, there was no 
difference in the number of retinal ganglion cells at PND60 (Figures 1A, 2A). (D) There were no differences in the number of TUNEL-positive cells in the ONL or INL 
between groups. In B–D, values are mean ± SE from four to seven retinas at each age per treatment group, with each retina from a different mouse. 
*p < 0.05 compared with control. 
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Because there are no similar GLE studies, 
we suggest three logical non-mutually exclu-
sive possible mechanisms that could produce 
the adult GLE phenotype. First, GLE could 
enhance the progression of the RPC cell cycle 
mediated by glutamate and ATP (Martins and 
Pearson 2008). For example, the pharmaco-
logi  c antagonism of glutamatergic α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA)/kainate and N-methyl-d-aspartic acid 
(NMDA) receptors increases RPC prolifera-
tion in developing mouse retinas (Martins 
and Pearson 2008). The non  competitive inhi-
bition of receptors for NMDA and kainate 
observed with 1–5 µM added lead (Alkondon 
et al. 1990; Musshoff et al. 1995) could 
increase RPC proliferation. Second, GLE 
might decrease nitric oxide synthase activity 
in the developing retina, which would increase 
RPC prolifera  tion. This idea is consistent with 
findings that nitric oxide regulates RPC pro-
liferation in chick embryo cells (Magalhães 
et al. 2006) and that moderate-level GLE and 
lactational lead exposure decreased neuronal 
nitric oxide synthase in rat brain (Chetty et al. 
2001). Third, GLE could selectively increase a 
sub    population of RPCs that share a late-born 
neuronal cell fate, because approximately 20% 
of all multiple cell clones in rat RPC lineage- 
tracing studies contained rods and BCs (Turner 
and Cepko 1987). Thus, this novel GLE model 
could help uncover the pathways that establish 
early- and late-born RPCs and specify neuronal 
versus MGC fate.
Conclusion
Our results show that GLE in mice with [BPb] 
at the current low level of concern (CDC 
1991) produced persistent retinal altera-
tions characterized by proportional increases 
in rod and rod BC neuro  genesis that likely 
under  lie the observed scotopic ERG super-
normality (Fox et al. 2008; Lilienthal et al. 
1994; Nagpal and Brodie 2009; Rothenberg 
et al. 2002). In concert with our previous work 
(Fox and Boyes 2008), these findings stress 
the importance of examining developmental- 
stage–dependent and dose-dependent effects 
in human and animal toxicology studies. 
The non  monotonic effects suggest that HD 
GLE also triggered rod apoptosis similar to 
that observed in mice and rats with postna-
tal-only lead exposure (Fox et al. 1997; He 
et al. 2003). These latter results are consis-
tent with findings of decreased prolifera  tion 
and/or neuro  genesis in rat hippocampus after 
GLE and lactational lead exposure with peak 
[BPb] > 40 µg/dL (Gilbert et al. 2005; Verina 
et al. 2007). Finally, as suggested by other 
retinal studies (Tan et al. 2001), the increased 
number of rods in GLE mice may accelerate 
age-related retinal degeneration. Our findings 
raise complex issues for neuro  toxicologists, 
pediatricians, public health regulators, and risk 
assessors.
RefeRences
Alexiades MR, Cepko C. 1996. Quantitative analysis of prolifera-
tion and cell cycle length during development of the rat 
retina. Dev Dyn 205:293–307.
Alkondon M, Costa AC, Radhakrishnan V, Aronstam RS, 
Albuquerque EX. 1990. Selective blockade of NMDA-
activated channel currents may be implicated in learning 
deficits caused by lead. FEBS Lett 261:124–130.
Barton KM, Levine EM. 2008. Expression patterns and cell cycle 
profiles of PCNA, MCM6, cyclin D1, cyclin A2, cyclin B1, 
and phosphorylated histone H3 in the developing mouse 
retina. Dev Dyn 237:672–682.
CDC (Centers for Disease Control and Prevention). 1991. 
Preventing Lead Poisoning in Young Children: A Statement 
by the Centers for Disease Control and Prevention. Atlanta, 
GA:CDC. 
Chetty CS, Reddy GR, Murthy KS, Johnson J, Sajwan K, Desiah D. 
2001. Perinatal lead exposure alters the expression of 
neuronal nitric oxide synthase in rat brain. Int J Toxicol 
20:113–120.
Fox DA, Boyes WK. 2008. Toxic responses of the ocular and 
visual system. In: Casarett and Doull’s Toxicology: The 
Science of Poisons (Klaassen CD, ed). 7th ed. New 
York:McGraw-Hill, 665–697. 
Fox DA, Campbell ML, Blocker YS. 1997. Functional alterations 
and apoptotic cell death in the retina following develop-
mental or adult lead exposure. Neurotoxicology 18:645–664.
Fox DA, Kala SV, Hamilton WR, Johnson JE, O’Callaghan JP. 
2008. Low-level human equivalent gestational lead expo-
sure produces supernormal scotopic electroretinograms, 
increased retinal neurogenesis and decreased dopamine 
utilization in rats. Environ Health Perspect 116:618–625.
Gilbert ME, Kelly ME, Samsam TE, Goodman JH. 2005. Chronic 
developmental lead exposure reduces neurogenesis in 
adult rat hippocampus but does not impair spatial learning. 
Toxicol Sci 86:365–374.
Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity 
of industrial chemicals. Lancet 368:2167–2178.
Green ES, Stubbs JL, Levine EM. 2003. Genetic rescue of cell 
number in a mouse model of microphthalmia: inter  actions 
between Chx10 and G1-phase cell cycle regulators. 
Development 130:539–552.
He L, Perkins GA, Poblenz AT, Harris JB, Hung M, Ellisman MH, 
et al. 2003. Bcl-xL overexpression blocks bax-mediated 
mitochondrial contact site formation and apoptosis in rod 
photo  receptors of lead-exposed mice. Proc Natl Acad Sci 
USA 100:1022–1027. 
He L, Poblenz AT, Medrano CJ, Fox DA. 2000. Lead and calcium 
produce rod photoreceptor cell apoptosis by opening the 
mitochondrial permeability transition pore. J Biol Chem 
275:12175–12184.
Jeon CJ, Strettoi E, Masland RH. 1998. The major cell popula-
tions of the mouse retina. J Neurosci 18:8936–8946.
Johnson JE Jr, Perkins GA, Giddabasappa A, Chaney S, 
Xiao W, White AD, et al. 2007. Spatiotemporal regulation of 
ATP and Ca2+ dynamics in vertebrate rod and cone ribbon 
synapses. Mol Vis 13:887–919.
Leasure JL, Giddabasappa A, Chaney S, Johnson JE Jr, 
Pothakos K, Lau YS, et al. 2008. Low-level human equivalent 
gestational lead exposure produces sex-specific motor and 
coordination abnormalities and late-onset obesity in year-
old mice. Environ Health Perspect 116:355–361.
Lilienthal H, Kohler K, Turfeld M, Winneke G. 1994. Persistent 
increases in scotopic B-wave amplitudes after lead expo-
sure in monkeys. Exp Eye Res 59:203–209.
Livesey FJ, Cepko CL. 2001. Vetebrate neural cell-fate determina-
tion: lessons from the retina. Nat Rev Neurosci 2:109–118.
Lucocq JM. 2007. Efficient quantitative morphological pheno-
typing of genetically altered organisms using stereology. 
Transgenic Res 16:133–145.
Magalhães CR, Socodato RE, Paes-de-Carvalho R. 2006. Nitric 
oxide regulates the proliferation of chick embryo retina 
cells by a cyclic GMP-independent mechanism. Int J Devel 
Neurosci 24:53–60.
Martins RA, Pearson RA. 2008. Control of cell proliferation by 
neurotransmitters in the developing vertebrate retina. 
Brain Res 1192:37–60.
Mendola P, Selevan SG, Gutter S, Rice D. 2002. Environmental 
factors associated with a spectrum of neurodevelopmental 
deficits. Ment Retard Dev Disabil Res Rev 8:188–197.
Musshoff U, Madeja M, Binding N, Witting U, Speckmann EJ. 
1995. Lead-induced blockage of kainate-sensitive recep-
tor channels. Naunyn Schmiedebergs Arch Pharmacol 
353:42–45.
Nagpal AG, Brodie SE. 2009. Supranormal electroretinogram 
in a 10-year-old girl with lead toxicity. Doc Ophthalmol 
118:163–166.
NIH (National Institutes of Health). 2002. Public Health Service 
Policy on the Humane Care and Use of Laboratory Animals. 
Available: http://grants.nih.gov/grants/olaw/references/
phspol.htm [accessed 5 June 2010].
NIH (National Institutes of Health). 2009. ImageJ (version 
1.38e). Available: http://rsb.info.nih.gov/ij/ [accessed 
6 February 2010].
Portera-Cailliau C, Sung CH, Nathans J, Adler R. 1994. Apoptotic 
photoreceptor cell death in mouse models of retinitis pig-
mentosa. Proc Natl Acad Sci USA 91:974–978.
Rachel RA, Dolen G, Hayes NL, Lu A, Erskine L, Nowakowski RS, 
et al. 2002. Spatiotemporal features of early neurono  genesis 
differ in wild-type and albino mouse retina. J Neurosci 
22:4249–4263.
Rice D, Barone S Jr. 2000. Critical periods of vulnerability for 
the developing nervous system: evidence from humans 
and animal models. Environ Health Perspect 108(suppl 
3):511–533.
Rice DS, Curran T. 2000. Disabled-1 is expressed in type AII ama-
crine cells in the mouse retina. J Comp Neurol 424:327–338.
Rothenberg SJ, Schnaas L, Salgado-Valladares M, Casanueva E, 
Geller AM, Hudnell HK, et al. 2002. Increased ERG a- and 
b-wave amplitudes in 7- to 10-year-old children resulting 
from prenatal lead exposure. Invest Ophthalmol Vis Sci 
43:2036–2044.
Strettoi E, Volpini M. 2002. Retinal organization in the bcl-2- 
overexpressing transgenic mouse. J Comp Neurol 446:1–10.
Tan E, Wang Q, Quiambao AB, Xu X, Qtaishat NM, Peachey NS, 
et al. 2001. The relationship between opsin overexpression 
and photoreceptor degeneration. Invest Ophthalmol Vis 
Sci 42:589–600.
Turner DL, Cepko CL. 1987. A common progenitor for neurons 
and glia persists in rat retina late in development. Nature 
328:131–136.
Verina T, Rohde CA, Guilarte TR. 2007. Environmental lead 
exposure during early life alters granule cell neurogenesis 
and morphology in the hippocampus of young adult rats. 
Neuroscience 145:1037–1047.
Young RW. 1984. Cell death during differentiation of the retina 
in the mouse. J Comp Neurol 229:362–373.
Young RW. 1985a. Cell differentiation in the retina of the mouse. 
Anat Rec 212:199–205.
Young RW. 1985b. Cell proliferation during postnatal develop-
ment of the retina in the mouse. Brain Res 353:229–239.